Cargando…

Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient

BACKGROUND: Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its comorbidities. Bariatric surgery, particularly biliopancreatic diversion with duod...

Descripción completa

Detalles Bibliográficos
Autores principales: Woods, Philippe, Paquette, Carmen, Martin, Julie, Dumesnil, Jean-Gaston, Marceau, Picard, Marceau, Simon, Biron, Simon, Hould, Frédéric, Lescelleur, Odette, Lebel, Stéphane, Poirier, Paul
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC416487/
https://www.ncbi.nlm.nih.gov/pubmed/15113416
http://dx.doi.org/10.1186/1475-2840-3-5
_version_ 1782121423220768768
author Woods, Philippe
Paquette, Carmen
Martin, Julie
Dumesnil, Jean-Gaston
Marceau, Picard
Marceau, Simon
Biron, Simon
Hould, Frédéric
Lescelleur, Odette
Lebel, Stéphane
Poirier, Paul
author_facet Woods, Philippe
Paquette, Carmen
Martin, Julie
Dumesnil, Jean-Gaston
Marceau, Picard
Marceau, Simon
Biron, Simon
Hould, Frédéric
Lescelleur, Odette
Lebel, Stéphane
Poirier, Paul
author_sort Woods, Philippe
collection PubMed
description BACKGROUND: Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its comorbidities. Bariatric surgery, particularly biliopancreatic diversion with duodenal switch reduces efficiently excess body weight and improves metabolic and cardiovascular functions. CASE PRESENTATION: A 56-year-old man with severe clinical obesity underwent a biliopancreatic diversion with a duodenal switch after unsuccessful treatment with weight loss pharmacotherapy. He had diabetes, hypertension and sleep apnea syndrome and was on three medications for hypertension and two hypoglycemic agents in addition to > 200 insulin units daily. Eleven months after the surgery, he had lost 40% of his body weight. The lipid profile showed great improvement and the hypertension and diabetes were more easily controlled with no more insulin needed. The pseudonormalized pattern of left ventricular diastolic function improved and ventricular walls showed decreased thickness. CONCLUSION: Biliopancreatic diversion may bring metabolic and cardiovascular benefits in severely obese patients from a cardiovascular perspective.
format Text
id pubmed-416487
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-4164872004-05-23 Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient Woods, Philippe Paquette, Carmen Martin, Julie Dumesnil, Jean-Gaston Marceau, Picard Marceau, Simon Biron, Simon Hould, Frédéric Lescelleur, Odette Lebel, Stéphane Poirier, Paul Cardiovasc Diabetol Case Report BACKGROUND: Severe obesity is associated with important morbidity and increased mortality. The successes of lifestyle modifications and drug therapy have been partial and mostly unsustained in reducing obesity and its comorbidities. Bariatric surgery, particularly biliopancreatic diversion with duodenal switch reduces efficiently excess body weight and improves metabolic and cardiovascular functions. CASE PRESENTATION: A 56-year-old man with severe clinical obesity underwent a biliopancreatic diversion with a duodenal switch after unsuccessful treatment with weight loss pharmacotherapy. He had diabetes, hypertension and sleep apnea syndrome and was on three medications for hypertension and two hypoglycemic agents in addition to > 200 insulin units daily. Eleven months after the surgery, he had lost 40% of his body weight. The lipid profile showed great improvement and the hypertension and diabetes were more easily controlled with no more insulin needed. The pseudonormalized pattern of left ventricular diastolic function improved and ventricular walls showed decreased thickness. CONCLUSION: Biliopancreatic diversion may bring metabolic and cardiovascular benefits in severely obese patients from a cardiovascular perspective. BioMed Central 2004-04-27 /pmc/articles/PMC416487/ /pubmed/15113416 http://dx.doi.org/10.1186/1475-2840-3-5 Text en Copyright © 2004 Woods et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Case Report
Woods, Philippe
Paquette, Carmen
Martin, Julie
Dumesnil, Jean-Gaston
Marceau, Picard
Marceau, Simon
Biron, Simon
Hould, Frédéric
Lescelleur, Odette
Lebel, Stéphane
Poirier, Paul
Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
title Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
title_full Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
title_fullStr Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
title_full_unstemmed Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
title_short Metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
title_sort metabolic and cardiovascular improvements after biliopancreatic diversion in a severely obese patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC416487/
https://www.ncbi.nlm.nih.gov/pubmed/15113416
http://dx.doi.org/10.1186/1475-2840-3-5
work_keys_str_mv AT woodsphilippe metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT paquettecarmen metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT martinjulie metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT dumesniljeangaston metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT marceaupicard metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT marceausimon metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT bironsimon metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT houldfrederic metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT lescelleurodette metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT lebelstephane metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient
AT poirierpaul metabolicandcardiovascularimprovementsafterbiliopancreaticdiversioninaseverelyobesepatient